United Health (UNH) Offering Possible 16.55% Return Over the Next 28 Calendar Days

United Health's most recent trend suggests a bearish bias. One trading opportunity on United Health is a Bear Call Spread using a strike $340.00 short call and a strike $360.00 long call offers a potential 16.55% return on risk over the next 28 calendar days. Maximum profit would be generated if the Bear Call Spread were to expire worthless, which would occur if the stock were below $340.00 by expiration. The full premium credit of $2.84 would be kept by the premium seller. The risk of $17.16 would be incurred if the stock rose above the $360.00 long call strike price.

The 5-day moving average is moving down which suggests that the short-term momentum for United Health is bearish and the probability of a decline in share price is higher if the stock starts trending.

The 20-day moving average is moving down which suggests that the medium-term momentum for United Health is bearish.

The RSI indicator is at 43.79 level which suggests that the stock is neither overbought nor oversold at this time.

To learn how to execute such a strategy while accounting for risk and reward in the context of smart portfolio management, and see how to trade live with a successful professional trader, view more here


LATEST NEWS for United Health

UNH Stock: Bearish Option Trade Could Yield A 54% Return
Wed, 17 Feb 2021 16:03:23 +0000
A bearish call spread can profit from strong resistance in UNH stock at the 50-day moving average, and has a wide profit range.

Leading $2.8 Trillion US Healthcare Market: CEO’s of Skylight Health, Oak Street, UnitedHealth Group, 1life Healthcare – Innovating Next Generation Healthcare Systems
Wed, 17 Feb 2021 14:43:00 +0000
NEW YORK, Feb. 17, 2021 (GLOBE NEWSWIRE) — Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: UnitedHealth Group (NYSE: UNH), Skylight Health Group (TSX.V: SHG) (OTC: SHGFF), 1life Healthcare (NASDAQ: ONEM), and Oak Street Health (NYSE: OSH). The US healthcare market is estimated at $2.8 trillion – and the largest in the world. Fast moving innovators are now driving a transformation wave – and creating new opportunities for investors. Wall Street Reporter highlights the latest comments from industry thought leaders: 1life Healthcare (NASDAQ: ONEM) Chairman & CEO, Amir Rubin: “New Market Expansions Provides Long Runway For Growth” “…Our membership count in the quarter surpassed the half a million mark. Q3 membership growth accelerated to 29% year-over-year with momentum across both consumer and enterprise channels, allowing us to reach our year-end membership guidance a quarter early…We also surpassed $100 million in net revenue for the first time in a single quarter, delivering $102 million in total net revenue in Q3, which grew 46% year-over-year. We delivered a care margin of $42.9 million or 42% of net revenue and positive adjusted EBITDA of $3.5 million or 3% of net revenue. These margin results demonstrate the strong leverage components of our model.” “…We are now operating in 12 markets across the United States up 50% over the last 18 months. Throughout 2020, we have expanded into new markets in partnership with both new and existing health network partners. ..by the end of 2021, we plan to have established physical presence in 17 markets, a 40% increase from our 12 markets today, and more than double the markets from where we were 18 months ago. Our partnerships and market expansions provide long runways for growth impact and returns as we increase our reach and value proposition to companies and consumers, while leveraging our technology and operating infrastructure.” 1life Healthcare (NASDAQ: ONEM) Earnings Highlights: https://bit.ly/35PBxGE Skylight Health Group (TSX.V: SHG) (OTC: SHGFF) CEO, Prad Sekar: “Now At Inflection Point – Positioned for 10X Upside Revenue Growth Potential” Skylight Health Group (TSX.V: SHG) (OTC: SHGFF) was recently a featured presenter at Wall Street Reporter’s NEXT SUPER STOCK livestream investor conference. CEO Prad Sekar, outlined his vision for building Skylight into a multi-billion dollar business focused on the highly fragmented US healthcare market. Skylight already operates 30 clinics, in 14 states, with virtual telehealth overlay, serving over 120,000 patients – and is one of the fastest growing multi-disciplinary health systems in the United States. FEBRUARY 17, 2021: Skylight (OTC: SHGFF) being featured in Wall Street Reporter’s NEXT SUPER STOCK livestream. Click to join: https://bit.ly/2PX0SpH Watch Skylight (OTC: SHGFF) Next Super Stock 2/2/21 video: http://bit.ly/3qvRidN Skylight is now at an inflection point. SHGFF revenues are expected to be $45 million and $5.5 million EBITDA run rates, with a recently announced acquisition. SHGFF boasts a profitable base of operations, no long-term debt and cash balance of $10 million. In his presentation, Skylight CEO Prad Sekar, explains how the company can increase revenues organically by about 10X, as it optimizes clinics for profitability by expansion of services to the existing patient base, with its proven business model, stating: “$200 Million Revenues Run Rate in 2021 Is Goal”. FEBRUARY 17, 2021: Skylight (OTC: SHGFF) being featured in Wall Street Reporter’s NEXT SUPER STOCK livestream. Click to join: https://bit.ly/2PX0SpH Watch Skylight (OTC: SHGFF) Next Super Stock 2/2/21 video: http://bit.ly/3qvRidN UnitedHealth Group (NYSE: UNH) CEO David Wichmann: “Building Next Generation Healthcare System” “…We continue to make important advancements and strategic investments to lay the foundation for the next generation health system. Over the last many years, you have heard us discuss our ambition to build high performing systems of care, including an aim to reinvent healthcare delivery, which is the first of our five strategic growth platforms. The foundations for those efforts are in our primary and multi-specialty care practices. OptumCare entered 2021 with over 50,000 physicians and 1,400 clinics. Over the course of this year, we expect to grow our employed and affiliated physicians by at least 10,000. This work of building local physician-led systems of care continues to be central to our mission and is accelerating with notable progress in the Northeast, Pacific Northwest, and Southern California in 2020…” “…UnitedHealthcare’s Medicaid offerings continued to grow strongly as well, including entry into three new states in 2021. New business opportunities are substantial with momentum towards managed care adoption by states and RFP activity accelerating this year and next. And while the economic effects of COVID-19 impacted UnitedHealthcare’s employer-sponsored growth in 2020, we are encouraged by the positive market response to the new highly consumer-centric offerings we have been discussing with you in recent months. Among these are digital first, on-demand, and physician-led products each provide deeply aligned modern, personal, and coordinated-care experiences and save people up to 20% compared to traditional offerings. These innovative products are generating significant responses because they are designed to better meet the unique needs and financial needs of more people. All-in, we expect UnitedHealthcare will grow in 2021 to serve upwards of 1.5 million more people across its senior community, employer-sponsored, and individual offerings.” UnitedHealth Group Incorporated (NYSE: UNH) Earnings Highlights: http://bit.ly/3qsVxag Oak Street Health (NYSE: OSH) CEO, Mike Pykosz: “Leading the Way in Primary Care for Older Adults” “…Our third quarter performance demonstrated the financial and operational strength of Oak Street's business model. We generated record revenue of $217.9 million, exceeding the top end of the guidance range we have communicated to investors. This represents an increase of 57% from third quarter 2019…We cared for roughly 59,500 at-risk patients, up 38% from third quarter 2019. We generated this patient growth despite essentially putting a halt on our community outreach and marketing efforts from early spring through midsummer due to uncertainties around COVID. “…We continue to look to scale our network of de novo centers…in addition to the 16 we opened in the first 9 months of 2020, we expect to open additional 6 to 8 stand-alone centers in the fourth quarter, bringing us to 22 to 24 openings for the year excluding our Walmart centers…We are also squarely focused on driving growth within our existing infrastructure. As a reminder, a typical Oak Street center can serve approximately 3,500 patients at full capacity, implying that our quarter-ending portfolio of 67 stand-alone centers has the capacity to care for approximately 235,000 patients, which is over 3.5x the actual patients on our platform in Q3. We are constantly refining, expanding and improving our outreach processes, embedding lessons learned throughout our history…” Oak Street Health (NYSE: OSH) Q3 2020 Earnings Highlights: https://bit.ly/35SQcRP WALL STREET REPORTER Wall Street Reporter (Est. 1843) is the leading financial news provider, focused on giving investors direct access to CEO's of promising, publicly-traded companies, and market experts. www.WallStreetReporter.com Nothing in this news summary shall be construed as investment advice. Quotes/content may be edited for brevity and context. Full disclaimer, and relevant SEC 17B disclosures here: http://bit.ly/39kkE7K About Wall Street Reporter’s Next Super Stock conference: Wall Street Reporter's NEXT SUPER STOCK Live! conference is dedicated to featuring select companies that have near-term catalysts in place which can drive transformational growth (and stock appreciation) in the months ahead. Click here to join next livestream event: https://www.wallstreetreporter.com/next-superstock-online-investor-conference/ CONTACT: WALL STREET REPORTER (212) 871-2057 ext 7 www.WallStreetReporter.com

Hedge Your Portfolio With This Bearish Option Trade in UNH Stock
Wed, 17 Feb 2021 09:33:31 +0000
For this options trade, we're taking a look at a bear put spread in UnitedHealth Group. Traders with a lot of bullish exposure may want to start hedging their bets by adding some bearish option trades in case the market takes a turn to the downside.

Top Insider Buys Highlight for the Week of Feb. 12
Sun, 14 Feb 2021 16:11:51 +0000
The largest Insider Buys this week were for UnitedHealth Group Inc, American Financial Group Inc, Crown Castle International Corp. and Anthem Inc

Health Savings Accounts: Find Out What's New, And 12 Best Accounts For 2021
Sat, 13 Feb 2021 00:06:08 +0000
Health care costs are top of mind as Covid-19 ravages the U.S. These best HSA accounts can help you handle your medical costs, and will bring tax benefits too.

Be Sociable, Share!

Related Posts

 

MarketTamer is not an investment advisor and is not registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory Authority. Further, owners, employees, agents or representatives of MarketTamer are not acting as investment advisors and might not be registered with the U.S. Securities and Exchange Commission or the Financial Industry Regulatory.


This company makes no representations or warranties concerning the products, practices or procedures of any company or entity mentioned or recommended in this email, and makes no representations or warranties concerning said company or entity’s compliance with applicable laws and regulations, including, but not limited to, regulations promulgated by the SEC or the CFTC. The sender of this email may receive a portion of the proceeds from the sale of any products or services offered by a company or entity mentioned or recommended in this email. The recipient of this email assumes responsibility for conducting its own due diligence on the aforementioned company or entity and assumes full responsibility, and releases the sender from liability, for any purchase or order made from any company or entity mentioned or recommended in this email.


The content on any of MarketTamer websites, products or communication is for educational purposes only. Nothing in its products, services, or communications shall be construed as a solicitation and/or recommendation to buy or sell a security. Trading stocks, options and other securities involves risk. The risk of loss in trading securities can be substantial. The risk involved with trading stocks, options and other securities is not suitable for all investors. Prior to buying or selling an option, an investor must evaluate his/her own personal financial situation and consider all relevant risk factors. See: Characteristics and Risks of Standardized Options. The www.MarketTamer.com educational training program and software services are provided to improve financial understanding.


The information presented in this site is not intended to be used as the sole basis of any investment decisions, nor should it be construed as advice designed to meet the investment needs of any particular investor. Nothing in our research constitutes legal, accounting or tax advice or individually tailored investment advice. Our research is prepared for general circulation and has been prepared without regard to the individual financial circumstances and objectives of persons who receive or obtain access to it. Our research is based on sources that we believe to be reliable. However, we do not make any representation or warranty, expressed or implied, as to the accuracy of our research, the completeness, or correctness or make any guarantee or other promise as to any results that may be obtained from using our research. To the maximum extent permitted by law, neither we, any of our affiliates, nor any other person, shall have any liability whatsoever to any person for any loss or expense, whether direct, indirect, consequential, incidental or otherwise, arising from or relating in any way to any use of or reliance on our research or the information contained therein. Some discussions contain forward looking statements which are based on current expectations and differences can be expected. All of our research, including the estimates, opinions and information contained therein, reflects our judgment as of the publication or other dissemination date of the research and is subject to change without notice. Further, we expressly disclaim any responsibility to update such research. Investing involves substantial risk. Past performance is not a guarantee of future results, and a loss of original capital may occur. No one receiving or accessing our research should make any investment decision without first consulting his or her own personal financial advisor and conducting his or her own research and due diligence, including carefully reviewing any applicable prospectuses, press releases, reports and other public filings of the issuer of any securities being considered. None of the information presented should be construed as an offer to sell or buy any particular security. As always, use your best judgment when investing.